Innovation economics is based on two fundamental tenets. One is that the central goal of economic policy should be to spur higher productivity and greater innovation. Second, markets relying on price signals alone will not always be as effective as smart public-private partnerships in spurring higher productivity and greater innovation. This is in contrast to the two other conventional economic doctrines, neoclassical economics and Keynesian economics.
A journal is a periodical publication intended to further progress of science, usually by reporting new research. Most journals are highly specialized, although some of the oldest journals publish articles, reviews, editorials, short communications, letters, and scientific papers across a wide range of scientific fields. Journals contain articles that peer reviewed, in an attempt to ensure that articles meet the journal's standards of quality, and scientific validity. Each such journal article becomes part of the permanent scientific record.
International Journal of Economics & Management Sciences (IJEMS) is one of the best Fully refered journal on Innovation Policy and the Economy. This journal publishes theoretical, empirical and experimental papers that significantly contribute to the disciplines of Telecommunications, Currency, Life marketing, Inflation, Stock Exchange, Exchange Rate, Investment, Marketing Management, Economics of Standards, Modern Inputs, Technological Change, Microfinance, etc. Using a wide range of research methods including statistical analysis, analytical work, case studies, field research, book reviews, literature surveys, historical analysis and articles examining significant research questions from a broad range of perspectives in Economics and Management Sciences body of knowledge are encouraged to be sent to IJEMS.
OMICS Group International is a reputed online open access journal provider and scientific event organizer. With over 700+ peer-reviewed journals and 3000+ International Scientific Conferences to our credit we cover all spheres of Clinical, Medical, Life Sciences, Engineering & Applied Sciences, Omics & Management and Pharmaceutical sciences. A team of over 50,000+ experts from Industry and Academia provide editorial support to our journals. OMICS Group International has already signed agreement with more than 1000+ Scientific associations worldwide to make health care and scientific information open access.
Last date updated on June, 2014